Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Head Neck ; 46(5): 1146-1151, 2024 May.
Article in English | MEDLINE | ID: mdl-38465445

ABSTRACT

OBJECTIVE: Lateral neck dissection (LND) is performed for staging/treatment of head and neck lesions. This traditionally includes placement of a drain and inpatient admission. Drainless, day-case head and neck surgery is attractive due to cost-effectiveness and reduced length of stay, but evidence is lacking in LND. We aim to investigate Artiss™ as an alternative to drain placement, facilitating day-case LND. METHODS: A prospective review was conducted of patients who underwent LND in a UK hospital over a 22-month period. RESULTS: Thirty-nine patients were identified (27 Artiss™ only; 12 Artiss™ with a drain). Eight Artiss™ only patients were day-case. All drains were removed by post-operative day 2. There was no statistically significant difference in the number of complications between the two groups. CONCLUSION: This observational study demonstrates that for selected patients, Artiss™ could facilitate drainless, day-case LND. Further controlled studies with matched groups and larger numbers are required to validate this.


Subject(s)
Fibrin Tissue Adhesive , Neck Dissection , Humans , Drainage , Fibrin Tissue Adhesive/therapeutic use , Hospitalization , Neck Dissection/methods , Prospective Studies
2.
BMC Med Res Methodol ; 22(1): 189, 2022 07 11.
Article in English | MEDLINE | ID: mdl-35818027

ABSTRACT

BACKGROUND: Methods for developing national recommendations vary widely. The successful adoption of new guidance into routine practice is dependent on buy-in from the clinicians delivering day-to-day patient care and must be considerate of existing resource constraints, as well as being aspirational in its scope. This initiative aimed to produce guidelines for the management of head and neck squamous cell carcinoma of unknown primary (HNSCCUP) using a novel methodology to maximise the likelihood of national adoption. METHODS: A voluntary steering committee oversaw 3 phases of development: 1) clarification of topic areas, data collection and assimilation, including systematic reviews and a National Audit of Practice; 2) a National Consensus Day, presenting data from the above to generate candidate consensus statements for indicative voting by attendees; and 3) a National Delphi Exercise seeking agreement on the candidate consensus statements, including representatives from all 58 UK Head and Neck Multidisciplinary Teams (MDT). Methodology was published online in advance of the Consensus Day and Delphi exercise. RESULTS: Four topic areas were identified to frame guideline development. The National Consensus Day was attended by 227 participants (54 in-person and 173 virtual). Results from 7 new systematic reviews were presented, alongside 7 expert stakeholder presentations and interim data from the National Audit and from relevant ongoing Clinical Trials. This resulted in the generation of 35 statements for indicative voting by attendees which, following steering committee ratification, led to 30 statements entering the National Delphi exercise. After 3 rounds (with a further statement added after round 1), 27 statements had reached 'strong agreement' (n = 25, 2, 0 for each round, respectively), a single statement achieved 'agreement' only (round 3), and 'no agreement' could be reached for 3 statements (response rate 98% for each round). Subsequently, 28 statements were adopted into the National MDT Guidelines for HNSCCUP. CONCLUSIONS: The described methodology demonstrated an effective multi-phase strategy for the development of national practice recommendations. It may serve as a cost-effective model for future guideline development for controversial or rare conditions where there is a paucity of available evidence or where there is significant variability in management practices across a healthcare service.


Subject(s)
Delphi Technique , Consensus , Cost-Benefit Analysis , Humans
3.
BMJ Case Rep ; 15(3)2022 Mar 04.
Article in English | MEDLINE | ID: mdl-35246437

ABSTRACT

Ectopic parathyroid adenomas are a rare congenital anomaly despite the complex migration parathyroid glands undergo during development. Rarer still, these can be found in the hypopharynx, become adenomas and be the cause of primary hyperparathyroidism. We present a case of a woman in her 50s who underwent transoral robotic surgery (TORS) to remove her hypopharyngeal ectopic parathyroid adenoma and cure her primary hyperparathyroidism without complication. This is a radical change in practice compared with traditional open, transverse cervical approaches. We demonstrate the efficacy of using TORS for this unusual case, highlighting its versatility and the need to continue to search for opportunities to best use this advancing technology, especially when it can improve patient outcomes.


Subject(s)
Hyperparathyroidism, Primary , Parathyroid Neoplasms , Robotic Surgical Procedures , Female , Humans , Hyperparathyroidism, Primary/etiology , Hyperparathyroidism, Primary/surgery , Hypopharynx , Parathyroid Glands/surgery , Parathyroid Neoplasms/complications , Parathyroid Neoplasms/surgery
4.
Head Neck ; 35(9): E277-9, 2013 Sep.
Article in English | MEDLINE | ID: mdl-22972594

ABSTRACT

BACKGROUND: We report a case of laryngeal leishmaniasis in a United Kingdom (UK) resident who lived in Spain for 5 years. METHODS AND RESULTS: The patient presented with a history of hoarseness. He had returned to the UK after spending 5 years in Spain as a retiree. His past medical history includes chronic obstructive pulmonary disease (COPD). Histology of a vocal cord biopsy was suggestive of leishmaniasis and polymerase chain reaction (PCR) test was positive for Leishmania donovani. His use of steroid inhaler probably contributed to his acquiring this extremely unusual infection. He was successfully treated with intravenous amphotericin. CONCLUSIONS: Laryngeal leishmaniasis is an extremely rare infection and is rarely reported in the UK. The ease of travel ensures that many tropical infections may present to UK clinicians.


Subject(s)
Laryngeal Diseases/diagnosis , Leishmania donovani/isolation & purification , Leishmaniasis, Visceral/diagnosis , Aged, 80 and over , Amphotericin B/therapeutic use , Antiprotozoal Agents/therapeutic use , DNA, Protozoan/genetics , Humans , Laryngeal Diseases/drug therapy , Laryngeal Diseases/parasitology , Leishmania donovani/genetics , Leishmaniasis, Visceral/drug therapy , Leishmaniasis, Visceral/parasitology , Male , Neglected Diseases , Polymerase Chain Reaction , Travel
SELECTION OF CITATIONS
SEARCH DETAIL
...